SavedAdd your journal

Journals / New Trends in Medicine Sciences / 2026 / Volume: 7 Issue: 2

Antibiotic Resistance Profile of Klebsiella Isolates from Intensive Care Units: A Retrospective Evaluation

Murat Aydın(Erzurum Bölge Eğitim ve Araştırma Hastanesi)0000-0002-0167-0802
Nurten Nur Aydın(Erzurum Bölge Eğitim ve Araştırma Hastanesi)0000-0003-4138-2490
Mehtap Hülya Aslan(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ERZURUM TIP FAKÜLTESİ, ERZURUM TIP PR.)0000-0002-8455-5120
Pages
—
Publication Date
2026-06-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall resistance rates to carbapenems were 52.2% for imipenem and 53.6% for meropenem.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study aimed to evaluate antibiotic resistance rates of Klebsiella isolates obtained from patients in the intensive care unit (ICU) of a tertiary hospital.
📊
Key Findings & Data:Klebsiella isolates cultured from clinical specimens of adult ICU patients between June 2021 and December 2023 were analyzed retrospectively.
💡
Conclusion & Impact:Overall resistance rates to carbapenems were 52.2% for imipenem and 53.6% for meropenem.
🔬Design:Research Article
📍Scope:2021 Verileri
⚙️Variables:Klebsiella · Intensive care unit · Antibiotic resistance

Abstract

This study aimed to evaluate antibiotic resistance rates of Klebsiella isolates obtained from patients in the intensive care unit (ICU) of a tertiary hospital. Klebsiella isolates cultured from clinical specimens of adult ICU patients between June 2021 and December 2023 were analyzed retrospectively. Demographic data and microbiological results were obtained from the hospital information system. A total of 416 Klebsiella strains were isolated from 337 patients. The mean age was 71±14.9 years, with 52.2% male. The most common sample type was tracheal aspirate (44.0%), followed by urine (27.6%), blood (18.3%), and other specimens (9.1%). Extended-spectrum beta-lactamase (ESBL) production was detected in 326 isolates (78.4%). In this group, resistance to imipenem and meropenem was found to be 66.3% and 68.1%, respectively, while both rates were 1.1% among ESBL-negative isolates. Colistin resistance was observed in 17.8% of ESBL-positive strains, while only one (1.1%) ESBL-negative isolate was resistant. Overall resistance rates to carbapenems were 52.2% for imipenem and 53.6% for meropenem. The highest overall resistance rates were for ceftriaxone (78.4%), ceftazidime (77.2%), and ciprofloxacin (69.5%). The lowest resistance rates were observed for amikacin (31.0%) and colistin (14.2%). Annually, ESBL positivity rose from 73.7% in 2021 to 75.5% in 2022 and 83.1% in 2023. High rates of ESBL production and carbapenem resistance have been observed among Klebsiella isolates from ICUs, with carbapenem resistance exceeding 65% in ESBL-positive isolates, thereby limiting empirical treatment options. These findings underscore the urgent need to develop up-to-date antibiotic policies based on local resistance data and to strengthen effective antibiotic management programmes.

🔖

Cite This Article

Aydın, M., Aydın, N. N., Aslan, M. H. (2026). Antibiotic Resistance Profile of Klebsiella Isolates from Intensive Care Units: A Retrospective Evaluation. New Trends in Medicine Sciences, Volume: 7 Issue: 2. https://doi.org/10.56766/ntms.1862290

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (22)

  1. Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011). Diagn Microbiol Infect Dis. 2014;78(4):443-48.
  2. Segatore B, Setacci D, Perilli M, et al. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex β-lactamase patterns including extended-spectrum enzymes. Int J Antimicrob Agents. 2004;23(5):480-86.
  3. Livermore DM. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995;8(4):557-84.
  4. Eftekhar F, Naseh Z. Extended-spectrum β-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumoniae. Iran J Microbiol. 2015;7(3):144.
  5. Barış A, Bulut ME, Öncül A, Bayraktar B. Yoğun Bakım Ünitelerinde Yatan Hastalara Ait Klinik İzolatların Tür Dağılımı ve Antibiyotik Duyarlılıkları. Turk J Intensive Care. 2017;15(1).
  6. Uzun B, Güngör S, Yurtsever Sg, Afşar İ, Demirci M. Yoğun Bakim Hastalarinin Kan Kültürlerinden İzole Edilen Pseudomonas Aeruginosa Ve Acinetobacter Baumannii Suşlarının Çeşitli Antibiyotiklere Direnç Durumları. Ankem Derg. 2012;26(2):55-60.
  7. The European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. Version 14.0 2024 [Available from: http://www.eucast.org.
  8. Yang J, Long H, Hu Y, Feng Y, McNally A, Zong Z. Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence. Clin Microbiol Rev. 2022;35(1):e0000621.
  9. Ochońska D, Brzychczy-Włoch M. Klebsiella Pneumoniae–Taxonomy, Occurrence, Identification, Virulence Factors and Pathogenicity. Adv Microbiol. 2024;63(3).
  10. Dursun ZB, Aydın S, Çelik İ. Yoğun Bakım Ünitesinde Bakteremi Nedeni Olan Mikroorganizmalar ve Antibiyotik Duyarlılıkları. Flora. 2019;24(3):183-9.
  11. Taş SŞ, Kahveci K. Uzun Süreli Yoğun Bakım Ünitesi ve Palyatif Bakım Merkezinde Hastane Enfeksiyonlarının Sürveyansı; 3 Yıllık Analiz. Cagdas Tip Derg. 2018;8(1):55-9.
  12. Balıkçı H, Açıkgöz Zc, Güvenman S, Çelikbilek N, Özdem B. Escherichia coli ve i Klebsiella İ spp. İzolatlarında a Plazmid Kaynaklı AmpC Beta-Laktamaz Üretiminin Araştırılması. Mikrobiyol Bul. 2014;48(1):82-93.
  13. Karamanlıoğlu D, Aysert-Yıldız P, Kaya M, Sarı N. İdrar kültürlerinden izole edilen enterik bakterilerde genişlemiş spektrumlu β-laktamaz oluşturma sıklığı ve antibiyotik duyarlılıkları. Klimik Derg. 2019;32(3):233-9.
  14. Kahraman EP, Karakeçe E, Erdoğan F, Uluyurt H, Köroğlu M, Çiftci İH. Klebsiella pneumoniae izolatlarının antibiyotiklere direnç durumlarının değerlendirilmesi. Ortadogu Med J. 2017;9(1):12-8.
  15. ŞanaL L, Tümtürk A. Sağlık Bakımı ile İlişkili İnfeksiyonlardan İzole Edilen Escherichia coli ve Klebsiella pneumoniae Suşlarında Genişlemiş Spektrumlu Beta-Laktamaz Sıklığı: 4 Yıllık Bir Çalışma. Flora. 2019;24(1):32-6.
  16. Doğanay D, Aydın M, Avşar İS. Farkli Klinik Örneklerden İzole Edilmiş Klebsiella Pneumoniae İzolatlarinin Antibiyotik Direnç Profilinin İncelenmesi: Covid-19 Pandemisi Sürecindeki Bir Yillik Veriler. J Fac Pharm Ankara. 2023;47(1):185-95.
  17. Duman Y, Kuzucu C, Tekerekoglu MS, Cakil B, Yakupogullari Y, Kaysadu H. Changing trends of carbapenem resistance of Escherichia coli and Klebsiella pneumoniae strains isolated from intensive care units, inpatient services and outpatient’s clinics: a five years retrospective analysis. Med Science. 2018;7(3):536-9.
  18. Tümtürk A, Tekçe AYT, Şanal L. Nozokomiyal infeksiyon etkeni Gram negatif bakterilerde karbapenem direnç oranları: Üçüncü basamak bir hastaneden retrospektif bir çalışma. Ortadogu Med J. 2019;11(4):422-6.
  19. Koçak AA, Yayla B, Güçlü AÜ, et al. Adana’da bir üniversite hastanesinde izole edilen solunum yolu patojenleri ve antibiyotik direnç profillerinin değerlendirilmesi. Türk Mikrobiyoloji Cem Derg. 2019;49(4):226-32.
  20. Duran H, Çeçen N, Atik B. Escherichia coli ve klebsiella pneumoniae türlerinde antibiyotik direnci ne durumda? Yoğun bakım ünitesinden beş yıllık analiz. Firat Tip Derg. 2022.
  21. Duran H, Çeken N, Atik TK. İdrar kültüründen izole edilen Escherichia coli ve Klebsiella pneumoniae suşlarının antibiyotik direnç oranları: Dört yıllık analiz. Ankem Derg. 2020;34(2):41-7.
  22. The European Committee on Antimicrobial Susceptibility Testing. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 2.0. Published 2017. Accessed May 2025. https://www.eucast.org/